Moneycontrol
HomeNewsBusinessTRIPS pact waiver for tackling COVID-19 to help save lives, recover trade: India to WTO
Trending Topics

TRIPS pact waiver for tackling COVID-19 to help save lives, recover trade: India to WTO

The proposal for temporary waiver from certain provisions of TRIPS agreement is first on priority list, he has said during the formal TNC (trade negotiations committee) and informal HODs (head of delegations) meetings on May 3.

May 05, 2021 / 22:34 IST
Story continues below Advertisement

Representational image

A temporary waiver of certain provisions of intellectual property rights' agreement for tackling COVID-19 will help in saving valuable human lives and accelerate the recovery of global trade and world GDP, according to Brajendra Navnit, Indian Ambassador and Permanent Representative to the World Trade Organisation. The proposal for temporary waiver from certain provisions of TRIPS agreement is first on priority list, he has said during the formal TNC (trade negotiations committee) and informal HODs (head of delegations) meetings on May 3.

To slow down the virus' ability to infect new people and mutate further, there is a need for a true global vaccination drive in a time boundmanner, and the limited waiver is an effective and pragmatic way to help in achieving it, Navnit said. "An outcome on this will not only help in saving valuable human lives but will also give a comforting signal to boost the consumer confidence and will accelerate the recovery of global trade and world GDP," he added.

Story continues below Advertisement

Insurers may reject your COVID-19 policy claim - here is why

In October 2020, India and South Africa submitted a proposal suggesting a waiver for all WTO (World Trade Organization) members on the implementation, application and enforcement of certain provisions of the TRIPS Agreement in relation to the prevention, containment or treatment of COVID-19. The agreement on Trade-Related Aspects of Intellectual Property Rights or TRIPS came into effect in January 1995. It is a multilateral agreement on intellectual property (IP) rights such as copyright, industrial designs, patents and protection of undisclosed information or trade secrets.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show